Glanbia launches further share buyback

Glanbia launches further share buyback of up to €50m

4 June 2025, Glanbia plc, the Better Nutrition company, (the "Company" or the "Group") announces that, from today, it will commence a share buy-back programme of up to €50 million in total value in Glanbia plc ordinary shares ("Shares"). The purpose of the share buy-back programme is to reduce the share capital of the Company (any Shares repurchased for this purpose will be cancelled). This programme is being carried out under the €100 million share buyback authority announced by the Company on 26 February 2025.

Details of the programme 

The Company has entered into an agreement with J&E Davy ("Davy") to act as principal in relation to the purchase of the Company's Shares, within certain pre-set parameters.

The programme will run from 4 June 2025, through to 31 December 2025, unless otherwise terminated in accordance with the Company's agreement with Davy and prevailing authority.

Under the terms of the agreement, Davy will make purchases of the Shares under the buy-back programme independently of, and uninfluenced by, the Company. Purchases may continue during any closed period to which the Company is subject. The Company confirms that it currently has no unpublished inside information.

The share buy-back programme will be conducted within the limitations of the Company's general authority to repurchase shares as set out in Resolution 10 approved by the Company's shareholders at the 2025 Annual General Meeting ("AGM") on 30 April 2025 up to a maximum of 10% of the issued share capital of the Company as at 18 March 2025, being 25,634,283 ordinary shares, which has been reduced by 583,753 ordinary shares to 25,050,530 ordinary shares as a consequence of the part of the €50 million buyback announced by the Company on 6 November 2024 completed between 1 May 2025 and 30 May 2025.

The programme will be conducted in accordance with Chapter 9 of the Euronext Dublin Listing Rules and the relevant provisions of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation (EU) 2016/1052 (also as in force in the United Kingdom ("UK"), from time to time, including, where relevant, pursuant to the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as the rules of the Central Bank of Ireland.

ENDS

For further information contact:

Glanbia plc +353 56 777 2200

Mark Garvey, Group Finance Director

Liam Hennigan, Group Secretary & Head of Investor Relations: +353 86 046 8375

Lauren O'Sullivan, Investor Relations Manager +353 85 741 7861

Martha Kavanagh, Director of Corporate Affairs: +353 87 646 2006

Davy

Ivan Murphy/Ronan Veale +353 1 679 7788